Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Video Release: GlaxoSmithKline CFO Interviewied On Q3 Results With CFO, Simon Dingemans.

GlaxoSmithKline CFO interviewied on Q3 results with CFO, Simon Dingemans.

GSK reports sales growth +1%, earnings per share +16% and strong cash generation which has enabled the company to re-affirm its guidance for the full year. Simon Dingemans, CFO, gives an update on the emerging markets business.

Transcript is available for download from the video player.